Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- F-1 Registration statement (foreign)
- 1.1 Form of Placement Agent Agreement
- 4.1 Form of Pre-funded Warrant
- 4.2 Form of Common Warrant
- 4.3 Form of Warrant Agent Agreement
- 5.1 Opinion of Daniel Bloch, Canadian Counsel to the Registrant, As to the Validity of the Common Shares
- 5.2 Opinion of Greenberg Traurig, P.a., U.S. Counsel to the Registrant Counsel to the Registrant
- 23.1 Consent of Saturna Group Chxartered Professional Accountants LLP
- 23.2 Consent of Brightman Almagor Zohar & Co., a Firm In the Deloitte Global Network, Independent Registered Public Accounting Firm
- EX-FILING FEES Filing Fee Table
Associated filings
CMND similar filings
- 7 Feb 24 Registration statement (foreign)
- 13 Sep 23 Registration statement (foreign) (amended)
- 25 Jul 23 Registration statement (foreign) (amended)
- 17 Jul 23 Registration statement (foreign)
- 31 Mar 23 Registration statement (foreign) (amended)
- 28 Mar 23 Registration statement (foreign) (amended)
- 27 Mar 23 Registration statement (foreign)
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the reference to our firm under the caption “Experts” in the Registration Statement on Form F-1 and related Prospectus of Clearmind Medicine Inc. dated July 17, 2023, and to the incorporation by reference therein of our audit report dated March 8, 2022 (except as to Note 1(c) which is as of October 19, 2022), included in its Annual Report on Form 20-F for the year ended October 31, 2022, filed with the Securities and Exchange Commission.
/s/ SATURNA GROUP CHARTERED PROFESSIONAL ACCOUNTANTS LLP
SATURNA GROUP CHARTERED PROFESSIONAL ACCOUNTANTS LLP
Vancouver, Canada
July 17, 2023